# Botulinum Toxin for the Treatment of Depression

> **NCT00934687** · PHASE2 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 30 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** clostridium botulinum toxin type A neurotoxin complex
- **OTHER:** 0.9% NaCl solution

## Key facts

- **NCT ID:** NCT00934687
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00934687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00934687, "Botulinum Toxin for the Treatment of Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00934687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*